Phaos Technology Holdings (Caym (POAS)
Phaos Technology Holdings (Caym operates in the Medical - Devices industry of the Healthcare sector, headquartered in Singapore, CE, SG. The stock last traded at $0.18, down 6.96% on the session, giving a market capitalisation of $2.5M. On trailing twelve-month figures it carries a trailing P/E of -0.61, a net margin of -3063.1%. Its beta of 2.74 implies it has historically moved more than the broad market.
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
Phaos Technology Holdings (Caym is most often compared with the following Healthcare names: